F
Freeline Therapeutics
Stevenage, United Kingdom
Founded 2015 NASDAQ: FRLN
Gene Therapy Delivery Nanomedicine Nano-Bio Protein Nanoparticles Cell Therapy Nano Lipid Nanoparticles
About
AAV gene therapy for liver-targeted diseases
Company Details
- Type
- public
- Employees
- 150+
- Funding
- Public
Key Products
- FLT180a
- Liver Gene Therapy